192 related articles for article (PubMed ID: 30476722)
1. Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cell by inducing mitochondrial fragmentation and activating MAPK-JNK signalling pathway.
Zhang L; Li S; Wang R; Chen C; Ma W; Cai H
Biomed Pharmacother; 2019 Feb; 110():213-223. PubMed ID: 30476722
[TBL] [Abstract][Full Text] [Related]
2. IL-2 augments the sorafenib-induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway.
Ding X; Sun W; Chen J
Cancer Cell Int; 2018; 18():176. PubMed ID: 30459526
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
Manov I; Pollak Y; Broneshter R; Iancu TC
FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
[TBL] [Abstract][Full Text] [Related]
4. TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway.
Ji K; Lin K; Wang Y; Du L; Xu C; He N; Wang J; Liu Y; Liu Q
Cancer Cell Int; 2018; 18():117. PubMed ID: 30127666
[TBL] [Abstract][Full Text] [Related]
5. Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma.
Lin S; Hoffmann K; Gao C; Petrulionis M; Herr I; Schemmer P
J Pineal Res; 2017 Apr; 62(3):. PubMed ID: 28178378
[TBL] [Abstract][Full Text] [Related]
6. PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Evers BM
J Surg Res; 2012 Aug; 176(2):542-8. PubMed ID: 22261591
[TBL] [Abstract][Full Text] [Related]
7. Glibenclamide induces apoptosis by activating reactive oxygen species dependent JNK pathway in hepatocellular carcinoma cells.
Yan B; Peng Z; Xing X; Du C
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28801533
[TBL] [Abstract][Full Text] [Related]
8. Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.
Liu J; Wei X; Wu Y; Wang Y; Qiu Y; Shi J; Zhou H; Lu Z; Shao M; Yu L; Tong L
Cell Oncol (Dordr); 2016 Aug; 39(4):333-42. PubMed ID: 27016209
[TBL] [Abstract][Full Text] [Related]
9. JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells.
Heslop KA; Rovini A; Hunt EG; Fang D; Morris ME; Christie CF; Gooz MB; DeHart DN; Dang Y; Lemasters JJ; Maldonado EN
Biochem Pharmacol; 2020 Jan; 171():113728. PubMed ID: 31759978
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
Gao C; Li X; Yu S; Liang L
J BUON; 2019; 24(5):1964-1969. PubMed ID: 31786862
[TBL] [Abstract][Full Text] [Related]
11. Matrine has pro-apoptotic effects on liver cancer by triggering mitochondrial fission and activating Mst1-JNK signalling pathways.
Cao J; Wei R; Yao S
J Physiol Sci; 2019 Mar; 69(2):185-198. PubMed ID: 30155612
[TBL] [Abstract][Full Text] [Related]
12. Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
Sun L; Jiang Y; Yan X; Dai X; Huang C; Chen L; Li T; Zhang Y; Xiao H; Yang M; Xiang L; Zhang Y; Chen S; Li S; Chen A; He F; Lian J
Exp Cell Res; 2021 Sep; 406(1):112755. PubMed ID: 34332981
[TBL] [Abstract][Full Text] [Related]
13. Calf Spleen Extractive Injection (CSEI), a small peptides enriched extraction, induces human hepatocellular carcinoma cell apoptosis via ROS/MAPKs dependent mitochondrial pathway.
Jia D; Lu W; Zhang X; Cai G; Teng L; Wang X; Zhang M; Zeng Y; Liang C; Wang D
J Pharmacol Sci; 2016 Oct; 132(2):122-130. PubMed ID: 28314430
[TBL] [Abstract][Full Text] [Related]
14. AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).
Huynh H; Ngo VC; Koong HN; Poon D; Choo SP; Toh HC; Thng CH; Chow P; Ong HS; Chung A; Goh BC; Smith PD; Soo KC
J Hepatol; 2010 Jan; 52(1):79-87. PubMed ID: 19910069
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant Hep G2 cells through a mitochondria-dependent oxidative stress mechanism.
Chiou JF; Tai CJ; Wang YH; Liu TZ; Jen YM; Shiau CY
Cancer Biol Ther; 2009 Oct; 8(20):1904-13. PubMed ID: 19770576
[TBL] [Abstract][Full Text] [Related]
16. Increased effects of 2,5-dimethylcelecoxib on sensitivity of hepatocellular carcinoma cells to sorafenib via CYP3A5 expression and activation of AMPK.
Chen Y; Pan B; Qiu J; Chen Z; Wang X; Tang N
Toxicol In Vitro; 2021 Oct; 76():105226. PubMed ID: 34293431
[TBL] [Abstract][Full Text] [Related]
17. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib and FH535 in combination act synergistically on hepatocellular carcinoma by targeting cell bioenergetics and mitochondrial function.
Turcios L; Vilchez V; Acosta LF; Poyil P; Butterfield DA; Mitov M; Marti F; Gedaly R
Dig Liver Dis; 2017 Jun; 49(6):697-704. PubMed ID: 28179093
[TBL] [Abstract][Full Text] [Related]
20. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis.
Shi YH; Ding ZB; Zhou J; Hui B; Shi GM; Ke AW; Wang XY; Dai Z; Peng YF; Gu CY; Qiu SJ; Fan J
Autophagy; 2011 Oct; 7(10):1159-72. PubMed ID: 21691147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
